4//SEC Filing
Lofton Kevin E 4
Accession 0001127602-22-013724
CIK 0000882095other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 6:52 PM ET
Size
10.3 KB
Accession
0001127602-22-013724
Insider Transaction Report
Form 4
Lofton Kevin E
Director
Transactions
- Award
Common Stock
2022-05-05+2,444→ 95,192 total(indirect: By Trust) - Award
Non-qualified Stock Option (Right to Buy)
2022-05-05+15,851→ 15,851 totalExercise: $61.35Exp: 2032-05-05→ Common Stock (15,851 underlying)
Footnotes (3)
- [F1]Represents 2.444 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 5, 2022.
- [F2]Includes 65,874 shares held in a Revocable Living Trust and 29,318 shares held in a Grantor Retained Annuity Trust.
- [F3]100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022.
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001468818
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 6:52 PM ET
- Size
- 10.3 KB